Biomedical Enterprises
Designs and develops first-in-class medical devices with emphasis on therapies and diagnostics for bloodstream infections, hemodialysis-related complications, targeted temperature management, and automated urine cytology. Has conducted SBIR-funded translational research, device testing and validation, and collaborates with contract manufacturers for prototyping and regulatory support.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Plasma ultraviolet pathogen inactivation system
Device concept using ultraviolet treatment of plasma to inactivate pathogens for treatment of bloodstream infections lacking effective therapies.
Targeted temperature management (blood cooling/rewarming) system
System designed to cool and gradually rewarm blood to provide therapeutic hypothermia for post-cardiac arrest, traumatic brain injury, and selected neurosurgical patients.
Automated urine cytology screening system with AI
Automated system to prepare urine samples and apply AI-based microscopy to identify kidney and bladder cancer cells without human involvement.
Plasma ultraviolet pathogen inactivation system
Device concept using ultraviolet treatment of plasma to inactivate pathogens for treatment of bloodstream infections lacking effective therapies.
Targeted temperature management (blood cooling/rewarming) system
System designed to cool and gradually rewarm blood to provide therapeutic hypothermia for post-cardiac arrest, traumatic brain injury, and selected neurosurgical patients.
Automated urine cytology screening system with AI
Automated system to prepare urine samples and apply AI-based microscopy to identify kidney and bladder cancer cells without human involvement.
Services
Design and engineering of novel medical devices, including concept development and preparation for prototyping.
Coordination with FDA-registered contract manufacturer for prototyping, design-for-manufacture and testing.
Preparation of validation roadmaps and commercialization strategies for novel medical devices; experience with NIH SBIR funding.
Design and engineering of novel medical devices, including concept development and preparation for prototyping.
Coordination with FDA-registered contract manufacturer for prototyping, design-for-manufacture and testing.
Preparation of validation roadmaps and commercialization strategies for novel medical devices; experience with NIH SBIR funding.
Expertise Areas
- Medical device design and development
- Hemodialysis device development and blood-flow biomechanics
- Targeted temperature management (TTM) systems
- Plasma-based pathogen inactivation
Key Technologies
- Ultraviolet plasma pathogen inactivation
- Blood cooling and controlled rewarming systems
- Automated sample preparation
- AI-based image analysis for cytology
News & Updates
Company blog post discussing industry-specific content and the use of blog posts to communicate expertise and product value.
Obtained approximately $1.5M in SBIR grants from the National Institutes of Health to support device development.
Device (dialysis needle) selected by NIH for commercialization assistance.
Company blog post discussing industry-specific content and the use of blog posts to communicate expertise and product value.
Obtained approximately $1.5M in SBIR grants from the National Institutes of Health to support device development.
Device (dialysis needle) selected by NIH for commercialization assistance.